🇺🇸 FDA
Patent

US 8450489

Azaindoles useful as inhibitors of janus kinases

granted A61KA61K31/506A61K31/517

Quick answer

US patent 8450489 (Azaindoles useful as inhibitors of janus kinases) held by Vertex Pharmaceuticals Incorporated expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/506, A61K31/517, A61K31/53, A61K31/5377